FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2594200836> ?p ?o ?g. }

• W2594200836 endingPage "1421" @default.
• W2594200836 startingPage "1414" @default.
• W2594200836 abstract "Purpose: Slow-accruing clinical trials delay the translation of basic biomedical research, contribute to increasing health care costs, and may prohibit trials from reaching their original goals.Experimental Design: We analyzed a prospectively maintained institutional database that tracks all clinical studies at the MD Anderson Cancer Center (Houston, TX). Inclusion criteria were activated phase I-III trials, maximum projected accrual ≥10 participants, and activation prior to March 25, 2011. The primary outcome was slow accrual, defined as <2 participants per year. Correlations of trial characteristics with slow accrual were assessed with logistic regression.Results: A total of 4,269 clinical trials met inclusion criteria. Trials were activated between January 5, 1981, and March 25, 2011, with a total of 145,214 participants enrolled. Median total enrolment was 16 [interquartile range (IQR), 5-34], with an average enrolment rate of 8.7 participants per year (IQR, 3.3-17.7). There were 755 (18%) trials classified as slow accruing. On multivariable analysis, slow accrual exhibited robust associations with national cooperative group trials (OR = 4.16, P < 0.0001 vs. industry sponsored), time from trial activation to first enrolment (OR = 1.13 per month, P < 0.0001), and maximum targeted accrual (OR = 0.16 per log10 increase, P < 0.0001). Recursive partitioning analysis identified trials requiring more than 70 days (2.3 months) between activation and first participant enrolment as having higher odds of slow accrual (23% vs. 5%, OR = 5.56, P < 0.0001).Conclusions: We identified factors associated with slow trial accrual. Given the lack of data on clinical trials at the institutional level, these data will help build a foundation from which targeted initiatives may be developed to improve the clinical trial enterprise. Clin Cancer Res; 23(6); 1414-21. ©2017 AACR." @default.
• W2594200836 created "2017-03-16" @default.
• W2594200836 creator A5011564604 @default.
• W2594200836 creator A5017162434 @default.
• W2594200836 creator A5026095888 @default.
• W2594200836 creator A5041570474 @default.
• W2594200836 creator A5043534982 @default.
• W2594200836 creator A5061697254 @default.
• W2594200836 creator A5069422718 @default.
• W2594200836 creator A5071158497 @default.
• W2594200836 creator A5084622735 @default.
• W2594200836 creator A5084653105 @default.
• W2594200836 date "2017-03-14" @default.
• W2594200836 modified "2023-10-13" @default.
• W2594200836 title "Clinical Trial Characteristics and Barriers to Participant Accrual: The MD Anderson Cancer Center Experience over 30 years, a Historical Foundation for Trial Improvement" @default.
• W2594200836 cites W1524104891 @default.
• W2594200836 cites W1789241489 @default.
• W2594200836 cites W1969525589 @default.
• W2594200836 cites W2007419664 @default.
• W2594200836 cites W2025203811 @default.
• W2594200836 cites W2035935210 @default.
• W2594200836 cites W2050056063 @default.
• W2594200836 cites W2077033046 @default.
• W2594200836 cites W2091321319 @default.
• W2594200836 cites W2097284043 @default.
• W2594200836 cites W2103785603 @default.
• W2594200836 cites W2108747565 @default.
• W2594200836 cites W2128034114 @default.
• W2594200836 cites W2128681611 @default.
• W2594200836 cites W2130403270 @default.
• W2594200836 cites W2132047269 @default.
• W2594200836 cites W2141630251 @default.
• W2594200836 cites W2153730612 @default.
• W2594200836 cites W2157731916 @default.
• W2594200836 cites W2162361175 @default.
• W2594200836 cites W2165508079 @default.
• W2594200836 cites W2165552883 @default.
• W2594200836 cites W2207954566 @default.
• W2594200836 cites W2270764879 @default.
• W2594200836 cites W2471493685 @default.
• W2594200836 cites W2474664935 @default.
• W2594200836 cites W2549773109 @default.
• W2594200836 cites W4243634801 @default.
• W2594200836 doi "https://doi.org/10.1158/1078-0432.ccr-16-2439" @default.
• W2594200836 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5354950" @default.
• W2594200836 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28275168" @default.
• W2594200836 hasPublicationYear "2017" @default.
• W2594200836 type Work @default.
• W2594200836 sameAs 2594200836 @default.
• W2594200836 citedByCount "29" @default.
• W2594200836 countsByYear W25942008362017 @default.
• W2594200836 countsByYear W25942008362018 @default.
• W2594200836 countsByYear W25942008362019 @default.
• W2594200836 countsByYear W25942008362020 @default.
• W2594200836 countsByYear W25942008362021 @default.
• W2594200836 countsByYear W25942008362022 @default.
• W2594200836 countsByYear W25942008362023 @default.
• W2594200836 crossrefType "journal-article" @default.
• W2594200836 hasAuthorship W2594200836A5011564604 @default.
• W2594200836 hasAuthorship W2594200836A5017162434 @default.
• W2594200836 hasAuthorship W2594200836A5026095888 @default.
• W2594200836 hasAuthorship W2594200836A5041570474 @default.
• W2594200836 hasAuthorship W2594200836A5043534982 @default.
• W2594200836 hasAuthorship W2594200836A5061697254 @default.
• W2594200836 hasAuthorship W2594200836A5069422718 @default.
• W2594200836 hasAuthorship W2594200836A5071158497 @default.
• W2594200836 hasAuthorship W2594200836A5084622735 @default.
• W2594200836 hasAuthorship W2594200836A5084653105 @default.
• W2594200836 hasBestOaLocation W25942008361 @default.
• W2594200836 hasConcept C119060515 @default.
• W2594200836 hasConcept C121955636 @default.
• W2594200836 hasConcept C126322002 @default.
• W2594200836 hasConcept C144024400 @default.
• W2594200836 hasConcept C144133560 @default.
• W2594200836 hasConcept C149923435 @default.
• W2594200836 hasConcept C151956035 @default.
• W2594200836 hasConcept C156957248 @default.
• W2594200836 hasConcept C168563851 @default.
• W2594200836 hasConcept C203092338 @default.
• W2594200836 hasConcept C2781426361 @default.
• W2594200836 hasConcept C4577558 @default.
• W2594200836 hasConcept C535046627 @default.
• W2594200836 hasConcept C71924100 @default.
• W2594200836 hasConceptScore W2594200836C119060515 @default.
• W2594200836 hasConceptScore W2594200836C121955636 @default.
• W2594200836 hasConceptScore W2594200836C126322002 @default.
• W2594200836 hasConceptScore W2594200836C144024400 @default.
• W2594200836 hasConceptScore W2594200836C144133560 @default.
• W2594200836 hasConceptScore W2594200836C149923435 @default.
• W2594200836 hasConceptScore W2594200836C151956035 @default.
• W2594200836 hasConceptScore W2594200836C156957248 @default.
• W2594200836 hasConceptScore W2594200836C168563851 @default.
• W2594200836 hasConceptScore W2594200836C203092338 @default.
• W2594200836 hasConceptScore W2594200836C2781426361 @default.
• W2594200836 hasConceptScore W2594200836C4577558 @default.
• W2594200836 hasConceptScore W2594200836C535046627 @default.
• W2594200836 hasConceptScore W2594200836C71924100 @default.
• W2594200836 hasFunder F4320337351 @default.

• next